Healthcare

Levicept Presents Positive Phase II Data for Novel Neurotrophin-3 Inhibitor, LEVI-04, at 2025 World Congress on Osteoarthritis

Plenary presentation of data showing primary efficacy endpoint met – significant analgesia across all dosesSignificant improvement in all signs and...

Global Virtual Care Market to Surge: From $7.9 Billion in 2023 to $24.1 Billion by 2030 at a 19% CAGR | Valuates Reports

BANGALORE, India, April 25, 2025 /PRNewswire/ -- Virtual Care Market is Segmented by Type (Hospital-at-Home (HaH), Remote Therapeutic Monitoring (RTM),...

Global Virtual Care Market to Surge: From $7.9 Billion in 2023 to $24.1 Billion by 2030 at a 19% CAGR | Valuates Reports

BANGALORE, India, April 25, 2025 /PRNewswire/ -- Virtual Care Market is Segmented by Type (Hospital-at-Home (HaH), Remote Therapeutic Monitoring (RTM),...

error: Content is protected !!